clearsidebio.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Disallow: /wp-admin/ Allow: /wp-admin/admin-ajax.php Sitemap: | ||
Meta Tags
| Title | Clearside |
| Description | FIRST & ONLY FDA APPROVED PRODUCT FOR SUPRACHOROIDAL Search for: About Corporate Overview Leadership Board of Directors Scientific Advisory Board Technology Our Approach Suprachoroidal Space (SCS ® ) SCS Mic |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 107.21.8.129 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
clearsidebio.com Valuation
|
US$16,967,952
Last updated: 2023-04-30 04:06:33
clearsidebio.com has Semrush global rank of 623,782. clearsidebio.com has an estimated worth of US$ 16,967,952, based on its estimated Ads revenue. clearsidebio.com receives approximately 1,957,841 unique visitors each day. Its web server is located in United States, with IP address 107.21.8.129. According to SiteAdvisor, clearsidebio.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$16,967,952 |
| Daily Ads Revenue | US$15,663 |
| Monthly Ads Revenue | US$469,882 |
| Yearly Ads Revenue | US$5,638,581 |
| Daily Unique Visitors | 130,523 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| clearsidebio.com. | A | 3600 | IP: 107.21.8.129 |
| clearsidebio.com. | NS | 86400 | NS Record: ns3-02.azure-dns.org. |
| clearsidebio.com. | NS | 86400 | NS Record: ns4-02.azure-dns.info. |
| clearsidebio.com. | NS | 86400 | NS Record: ns1-02.azure-dns.com. |
| clearsidebio.com. | NS | 86400 | NS Record: ns2-02.azure-dns.net. |
| clearsidebio.com. | MX | 3600 | MX Record: 0 clearsidebio-com.mail.protection.outlook.com. |
| clearsidebio.com. | TXT | 3600 | TXT Record: google-site-verification=7BuOGsxK_XeV8t628nbrQipNX3CRAFJfh81IZKNHbhc |
| clearsidebio.com. | TXT | 3600 | TXT Record: adobe-sign-verification=e6f377974750708b4cba273453ef1da3 |
| clearsidebio.com. | TXT | 3600 | TXT Record: MS=D624DCB1127A4641F84ECF23B552EBC0D5DF5AF4 |
| clearsidebio.com. | TXT | 3600 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
HtmlToTextCheckTime:2023-04-30 04:06:33
| Search for: About Corporate Overview Leadership Board of Directors Scientific Advisory Board Technology Our Approach Suprachoroidal Space (SCS ® ) SCS Microinjector ® SCS Patient Videos Publications & Presentations Intellectual Property Pipeline Pipeline Overview CLS-AX Preclinical Development Gene Therapy Collaborations Products XIPERE ® Investors IR Overview News Events and Presentations Governance SEC Filings Financial Info Resources Clearside Biomedical clearsidebio 2022-05-22T00:09:17+00:00 LEARN ABOUT SUPRACHOROIDAL ADMINISTRATION FIRST & ONLY FDA APPROVED PRODUCT FOR SUPRACHOROIDAL ADMINISTRATION XIPERE ® (triamcinolone acetonide injectable suspension), for suprachoroidal use FIRST approved therapeutic delivered into the suprachoroidal space FIRST commercial product developed by Clearside FIRST therapy for macular edema associated with uveitis Learn About XIPERE® UNPRECEDENTED ACCESS TO THE BACK OF THE EYE We are redefining the treatment of retinal diseases. The back of the eye |
HTTP Headers
HTTP/1.1 301 Moved Permanently Server: nginx/1.16.1 Date: Fri, 22 Oct 2021 23:27:42 GMT Content-Type: text/html Content-Length: 169 Connection: keep-alive Location: https://www.clearsidebio.com/ HTTP/2 200 date: Fri, 22 Oct 2021 23:12:22 GMT content-type: text/html;charset=UTF-8 content-length: 37951 set-cookie: AWSALB=yi8dMqoqy3q/Nd3KsfJsHpX1WdUsOa5rOZH0VfUh8NEjgAe2X+IzefeAbXpCGviQ6zUdlt3sO7GDho0SIcqUr4pMVui/S3jIXTrhF8gW8qdLTaJJ9pGLCuk4zOQ0; Expires=Fri, 29 Oct 2021 23:12:22 GMT; Path=/ set-cookie: AWSALBCORS=yi8dMqoqy3q/Nd3KsfJsHpX1WdUsOa5rOZH0VfUh8NEjgAe2X+IzefeAbXpCGviQ6zUdlt3sO7GDho0SIcqUr4pMVui/S3jIXTrhF8gW8qdLTaJJ9pGLCuk4zOQ0; Expires=Fri, 29 Oct 2021 23:12:22 GMT; Path=/; SameSite=None; Secure server: Apache/2.4.46 (Ubuntu) ff-cache: c300|dc21/03/19:09/50/22|h125088|i2502 etag: ID2502 last-modified: Fri, 19 Mar 2021 13:50:22 GMT ff-version: 5.4.20 ff-cachecontrol: 0,ff-cache,ff-c-3-0-0|no-cache,no-store,max-age=0 cache-control: no-cache,no-store,max-age=0 strict-transport-security: max-age=31536000; includeSubdomains ff-pid: 200_992A59F378079398F098753A52BD1E25 ff-info: i211006110357:41729a8d1730a484,v content-language: en set-cookie: cfid=8f11a49e-c0f5-4d70-8400-5f6b2bb59e41;Path=/;Expires=Fri, 12-Nov-2021 00:51:54 UTC;HTTPOnly set-cookie: cftoken=0;Path=/;Expires=Fri, 12-Nov-2021 00:51:54 UTC;HTTPOnly set-cookie: SAMESITE=Lax;Path=/ set-cookie: JSESSIONID=10F18BAB72D74184C623B370755E9576;path=/;HttpOnly x-powered-by: Innovasium/iCMS-Ramsay2 x-powered-by-type: Live |
clearsidebio.com Whois Information
Domain Name: CLEARSIDEBIO.COM Registry Domain ID: 1669161822_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2021-07-29T01:59:21Z Creation Date: 2011-07-27T21:31:13Z Registry Expiry Date: 2023-07-27T21:31:13Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS1-02.AZURE-DNS.COM Name Server: NS2-02.AZURE-DNS.NET Name Server: NS3-02.AZURE-DNS.ORG Name Server: NS4-02.AZURE-DNS.INFO DNSSEC: unsigned >>> Last update of whois database: 2021-09-11T12:23:17Z <<< |